Anti-Fibrotic Actions of Interleukin-10 against Hypertrophic Scarring by Activation of PI3K/AKT and STAT3 Signaling Pathways in Scar-Forming Fibroblasts

PI3K/AKT/mTOR通路 蛋白激酶B 增生性瘢痕 癌症研究 磷酸化 信号转导 纤维化 生物 分子生物学 免疫印迹 车站3 STAT蛋白 细胞生物学 病理 医学 解剖 生物化学 基因
作者
Jihong Shi,Jun Li,Hao Guan,Weixia Cai,Xiaozhi Bai,Xiaobing Fang,Xiaolong Hu,Yaojun Wang,Hongtao Wang,Zhao Zheng,Linlin Su,Dahai Hu,Xiongxiang Zhu
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:9 (5): e98228-e98228 被引量:97
标识
DOI:10.1371/journal.pone.0098228
摘要

Background The hypertrophic scar (HS) is a serious fibrotic skin condition and a major clinical problem. Interleukin-10 (IL-10) has been identified as a prospective scar-improving compound based on preclinical trials. Our previous work showed that IL-10 has anti-fibrotic effects in transforming growth factor (TGF)-β1-stimulated fibroblasts, as well as potential therapeutic benefits for the prevention and reduction of scar formation. However, relatively little is known about the mechanisms underlying IL-10-mediated anti-fibrotic and scar-improvement actions. Objective To explore the expression of the IL-10 receptor in human HS tissue and primary HS fibroblasts (HSFs), and the molecular mechanisms contributing to the anti-fibrotic and scar-improvement capabilities of IL-10. Methods Expression of the IL-10 receptor was assessed in HS tissue and HSFs by immunohistochemistry, immunofluorescence microscopy, and polymerase chain reaction analysis. Primary HSFs were treated with IL-10, a specific phosphatidylinositol 3 kinase (PI3K) inhibitor (LY294002) or a function-blocking antibody against the IL-10 receptor (IL-10RB). Next, Western blot analysis was used to evaluate changes in the phosphorylation status of AKT and signal transducers and activators of transcription (STAT) 3, as well as the expression levels of fibrosis-related proteins. Results HS tissue and primary HSFs were characterized by expression of the IL-10 receptor and by high expression of fibrotic markers relative to normal controls. Primary HSFs expressed the IL-10 receptor, while IL-10 induced AKT and STAT3 phosphorylation in these cells. In addition, LY294002 blocked AKT and STAT phosphorylation, and also up-regulated expression levels of type I and type III collagen (Col 1 and Col 3) and alpha-smooth muscle actin (α-SMA) in IL-10-treated cells. Similarly, IL-10RB reduced STAT3/AKT phosphorylation and blocked the IL-10-mediated mitigation of fibrosis in HSFs. Conclusion IL-10 apparently inhibits fibrosis by activating AKT and STAT3 phosphorylation downstream of the IL-10 receptor, and by facilitating crosstalk between the PI3K/AKT and STAT3 signal transduction pathways.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
南攻完成签到,获得积分10
3秒前
威武幼荷完成签到 ,获得积分10
6秒前
LingMg完成签到 ,获得积分10
7秒前
Mois完成签到 ,获得积分10
9秒前
RRui完成签到,获得积分10
16秒前
深情大象完成签到,获得积分10
17秒前
小研家完成签到,获得积分10
18秒前
笨笨完成签到 ,获得积分10
19秒前
alexlpb完成签到,获得积分10
19秒前
笔墨纸砚完成签到 ,获得积分10
21秒前
Jessie完成签到,获得积分10
22秒前
wtian1221完成签到,获得积分10
22秒前
樂楽完成签到,获得积分10
31秒前
笑傲完成签到,获得积分10
32秒前
Stella完成签到 ,获得积分10
39秒前
调皮的手套完成签到,获得积分10
42秒前
腼腆的山兰完成签到 ,获得积分10
43秒前
bean完成签到,获得积分10
45秒前
49秒前
wewe发布了新的文献求助10
53秒前
内敛诚C完成签到 ,获得积分10
56秒前
junio完成签到 ,获得积分10
57秒前
在水一方的应助被小小旭呀采纳,获得10
57秒前
SciGPT的应助被科研通管家采纳,获得10
57秒前
CodeCraft的应助被科研通管家采纳,获得10
57秒前
隐形曼青的应助被科研通管家采纳,获得10
57秒前
小二郎的应助被科研通管家采纳,获得10
58秒前
李爱国的应助被科研通管家采纳,获得10
58秒前
噗愣噗愣地刚发芽完成签到 ,获得积分10
1分钟前
学习大王完成签到 ,获得积分10
1分钟前
华理附院孙文博完成签到 ,获得积分0
1分钟前
NexusExplorer的应助被wewe采纳,获得30
1分钟前
1分钟前
顾矜的应助被Wang采纳,获得10
1分钟前
1分钟前
舒适刺猬完成签到 ,获得积分10
1分钟前
Singularity完成签到,获得积分0
1分钟前
小小旭呀发布了新的文献求助10
1分钟前
1分钟前
憨憨完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185502
求助须知:如何正确求助?哪些是违规求助? 9574220
关于积分的说明 21834553
捐赠科研通 7783121
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481357